Vestal Point Capital »

Arcus Biosciences Incorporated shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Arcus Biosciences Incorporated (RCUS) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Arcus Biosciences Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Arcus Biosciences Incorporated held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcus Biosciences Incorporated by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.4M 250k 13.60

More positions owned by Vestal Point Capital

Ascendis Pharma A/S Sponsored Adr (ASND)
Arcellx Common Stock (ACLX)
Nuvalent Inc-a (NUVL)
Abivax SA Sponsored Ads (ABVX)
Alcon Ord Shs (ALC)
Bicara Therapeutics (BCAX)
Amicus Therapeutics (FOLD)
Globus Medical Cl A (GMED)
Ionis Pharmaceuticals (IONS)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Becton, Dickinson and (BDX)
Scholar Rock Hldg Corp (SRRK)
Immatics NV SHS (IMTX)
Repligen Corporation (RGEN)
Dianthus Therapeutics (DNTH)

View all positions for Vestal Point Capital

Top funds holding Arcus Biosciences Incorporated

Gilead Sciences
BlackRock
Vanguard Group
Point72 Asset Management
Woodline Partners
Suvretta Capital Management
State Street Corporation
Siren
FMR
Balyasny Asset Management
Geode Capital Management
Dimensional Fund Advisors
Morgan Stanley
Barclays
Bnp Paribas Investment Partners

View all funds holding Arcus Biosciences Incorporated